Diabetes mellitus and gout are ranked among the most common metabolic disorders in Western industrialised countries: According to figures published by the World Health Organization (WHO), around 60 ...

– RESET-RA is the first randomized, sham-controlled, double-blind trial to positively demonstrate the clinical potential of neuroimmune modulation for the treatment of rheumatoid arthritis (RA) – – ...

The European Alliance of Associations for Rheumatology – acknowledges the role of diverse real-world data to complement knowledge from randomised controlled trials. Data presented at the 2026 annual ...

The School of Infection & Immunity's Dr Eve Smith recently received the prestigious EULAR Abstract Award – FOREUM: Clinical Science at this year’s EULAR 2025 Congress. The world’s largest rheumatology ...

BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969), a leading biotech company, announced today that Professor Zhanguo Li, the leading PI, has presented latest data of BTK inhibitor orelabrutinib ...